Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 974 results

At the start of Childhood Cancer Awareness Month, we answer some of the most common questions we get around children's cancers. At the start of Childhood Cancer Awareness Month, we answer some of the most common questions we get around children's cancers.

by Cancer Research UK | Analysis | 1 September 2017

1 September 2017

  • Science & Technology
  • Health & Medicine

SABR: radiotherapy that's smart, fast and to the point

Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs. Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs.

by Gabriella Beer | Analysis | 21 August 2017

21 August 2017

This entry is part 5 of 11 in the series Radiotherapy
%postcontent%
This entry is part 27 of 30 in the series Our milestones
%postcontent%
An image of a darts board with a dart hitting the bulls-eye.

In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects. In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects.

by Michael Walsh | Analysis | 8 August 2017

8 August 2017

This entry is part 4 of 11 in the series Radiotherapy
%postcontent%
  • Charity News

Reviewing our year

Read about some of the progress we've made over the last financial year and about some of the big themes from the year. Read about some of the progress we've made over the last financial year and about some of the big themes from the year.

by Ali Glossop | Analysis | 20 July 2017

20 July 2017

This entry is part 26 of 30 in the series Our milestones
%postcontent%

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t. New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

by Justine Alford | Analysis | 27 June 2017

27 June 2017